Increased membrane surface positive charge and altered membrane fluidity leads to cationic antimicrobial peptide resistance in Enterococcus faecalis

Biochimica Et Biophysica Acta
Rashmi KumariyaAnita K Garsa

Abstract

To understand the role of cell membrane phospholipids during resistance development to cationic antimicrobial peptides (CAMPs) in Enterococcus faecalis, gradual dose-dependent single exposure pediocin-resistant (Pedr) mutants of E. faecalis (Efv2.1, Efv3.1, Efv3.2, Efv4.1, Efv4.2, Efv5.1, Efv5.2 and Efv5.3), conferring simultaneous resistance to other CAMPs, selected in previous study were characterized for cell membrane phospholipid head-groups and fatty acid composition. The involvement of phospholipids in resistance acquisition was confirmed by in vitro colorimetric assay using PDA (polydiacetylene)-biomimetic membranes. Estimation of ratio of amino-containing phospholipids to amino-lacking phospholipids suggests that phospholipids in cell membrane of Pedr mutants loose anionic character. At moderate level of resistance, the cell-membrane becomes neutralized while at further higher level of resistance, the cell-surface acquired positive charge. Increased expression of mprF gene (responsible for lysinylation of phospholipids) was also observed on acquiring resistance to pediocin in PedrE. faecalis. Decreased level of branched chain fatty acids in Pedr mutants might have contributed in enhancing rigidification of cell membrane...Continue Reading

References

Jun 1, 1991·Trends in Biochemical Sciences·D M Ojcius, J D Young
Feb 5, 2000·Nature Biotechnology·S KolushevaR Jelinek
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Sep 7, 2004·Microbiology·Viveka VadyvalooMarina Rautenbach
Jan 31, 2009·The New England Journal of Medicine·Cesar A Arias, Barbara E Murray
Jun 29, 2011·Antimicrobial Agents and Chemotherapy·Anna-Barbara HachmannJohn D Helmann
Sep 9, 2011·The New England Journal of Medicine·Cesar A AriasGeorge M Weinstock
Mar 1, 2013·Probiotics and Antimicrobial Proteins·S K SoodPuja Lather

❮ Previous
Next ❯

Citations

May 11, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Hwang-Soo JooMichael Otto
Jul 5, 2016·Frontiers in Cell and Developmental Biology·Rafi RashidKimberly A Kline
Jul 18, 2016·Biochimica Et Biophysica Acta·Luz N IrazazabalOctavio L Franco
Nov 16, 2016·Applied Biochemistry and Biotechnology·Manoj Kumar YadavSantosh Kumar Tiwari
Oct 23, 2019·Journal of Peptide Science : an Official Publication of the European Peptide Society·Milad AbdiNour Amirmozafari
Jun 12, 2019·International Journal of Molecular Sciences·Nereyda Niño-MartínezFacundo Ruiz
Sep 20, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yamil LiscanoJean Paul Delgado
Nov 5, 2020·Pharmaceutics·Olufunto T Fanoro, Oluwatobi S Oluwafemi
Nov 17, 2020·Frontiers in Microbiology·Lucas AssoniMichelle Darrieux
Nov 7, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wei-Hsuan LoChing-Hsuan Lin
Apr 4, 2021·Polymers·Cai-Ling KeChing-Hsuan Lin
Sep 25, 2021·Advanced Science·Mohammad J HajipourMorteza Mahmoudi
Oct 5, 2021·ACS Infectious Diseases·Lindsey N MillerTessa R Calhoun
Oct 27, 2021·Critical Reviews in Microbiology·Wolfgang BäumlerWulf Schneider-Brachert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.